Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 780. The contact email is not on this page.
- MicrobiotiX
Microbiotix, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases, including multi-drug resistant pathogens.
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GlycoSurf
GlycoSurf is a start-up chemical company focused on creating eco-friendly glycolipid surfactants derived from natural sugars. Their products are biodegradable, non-toxic, and designed for various applications including cleaning, cosmetics, and agriculture.
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ELIMU INFORMATICS, INC.
NIH R43: TIBSA: A tailored interoperable guideline-based clinical decision-support system for asthma
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SPIKE NEURO LLC
NIH R41: The development of a flexible carbon fiber penetrating nerve cuff and cortical array for neural recording, stimulation, and neurochemical detection
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CHARLES RIVER ANALYTICS, INC.
NIH R44: Novel, On-demand VR for Accessible, Practical, and Engaging therapy (NO VAPE)
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEOCARE INNOVATIONS, INC.
NIH R41: Pedi-Sync: A Clinical Decision Support Tool to Improve Oral Feeding Outcomes in Preterm Infants
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LOKI THERAPEUTICS, INC
NIH R42: Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patients
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GSNO THERAPEUTICS, INC.
NIH R43: Inhibition of Optic Nerve Degeneration
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC
NIH R44: In-vivo study of KSP/QRH heptapeptide dimer for detection of biliary intra-epithelial neoplasia
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HEMINGWAY DESIGNS, LLC
NIH R43: Lancet with dissolvable blade and biodegradable base
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- JAAN BIOTHERAPEUTICS, INC.
NIH R44: Heart Muscle Regeneration
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OP-T-MUNE, INC.
NIH R44: A Phase 2a Clinical Trail With a Drug that Targets CD40 Mediated Autoinflammation.
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- UNIVERSAL ADHERENCE, LLC
NIH R44: The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NANOMUSE, LLC
NIH R41: Next-generation nanomedicine for acute ischemic stroke
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ALTRUMED LLC
NIH R41: The DOVE Device to Prevent Opioid Overdose Deaths: An Armband That Senses Overdose and Automatically Injects Naloxone
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RAIZ DIAGNOSTICS, INC.
NIH R44: Scaling Lymphoma Diagnosis: A Cost-Effective Gene Expression Assay for Broad Implementation
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LITRON LABORATORIES, LTD.
NIH R44: Development of a Comprehensive Hen's Egg Model for Genotoxicity Testing
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CONWAY MEDICAL LLC
NIH R41: Lumbo-venous CSF Shunt for Treatment of Communicating Hydrocephalus.
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FOUNDATION INSTRUMENTS, INC.
NIH R43: SBIR Phase I: Evaluating the Feasibility of a HAA-Meter for Affordable, Onsite Monitoring of Haloacetic Acids in Drinking Water Plants with Advanced Machine Learning Chromatographic Interpretation
startup · TN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NemaMetrix Inc.
Form D history: Biotechnology
startup · OR · amount not stated · 2019-02-27
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2019-02-27.
- EVANESC THERAPEUTICS, INC.
NIH R43: Non-invasive Medical Device to Permeabilize the Blood-Brain Barrier Using Low Power Radio Frequency Evanescent Waves
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TELESAGE RESEARCH, INC.
NIH R44: Development of a cloud-based, self-report SUD intake system enabling primary care clinicians to routinely complete, implement, document, and bill for biopsychosocial assessments
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MOLECULAR TECHNOLOGIES LABORATORIES LLC
NIH R41: Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Inherent Biosciences
Inherent Biosciences is focused on revolutionizing reproductive health through epigenetic analysis and AI, aiming to improve fertility diagnostics and treatment plans.
startup · UT · amount not stated · 2023-05-31
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-05-31.
- DENTOSITY, LLC D/B/A VERTEX DISCOVERIES
NIH R43: Design and assembly of a trial-ready UVC LED device to kill endodontic microorganisms
startup · IA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LIGO ANALYTICS, INC.
NIH R44: Dynamical Diffraction Analysis for 3D Electron Crystallography
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MASTERSWITCH, INC.
NIH R44: Novel Nucleotide HNF4α Transcriptional Modulation for End Stage Liver Disease with Cirrhosis
startup · WILMINGTON, France · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OPIAID, INC.
NIH R44: Development of the OpiAID strength band platform
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Boston Immune Technologies and Therapeutics
Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies targeting TNF superfamily receptors with applications in oncology, inflammation, autoimmunity, and infectious disease.
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- D-PRIME LLC
NIH R43: Improved Patient Reported Outcomes (iPRO) -Sleep Diary: A Tool to Improve Sleep Assessment in Clinical Trials
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NUPEAK THERAPEUTICS, INC.
NIH R42: A New Small-Molecule Kinase Inhibitor for Airway Disease
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KINTARA THERAPEUTICS, INC.
NIH R44: An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Sensorium Therapeutics
Sensorium is a clinical-stage biotech developing first-in-class CNS therapies, guided by human biology and nature’s neuroactive patterns, to relieve suffering and restore wellbeing.
startup · MA · amount not stated · 2025-07-15
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-07-15.
- TEGA THERAPEUTICS, INC.
NIH R43: Title: New Clinical Biomarkers for GM1 Gamgliosidosis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CEREUS DIAGNOSTICS CORP.
NIH R44: Lung Cancer FAST (Fragment Analysis, SNP, and Translocations) Testing
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- THORMED INNOVATION LLC
NIH R41: Non Invasive Urine Output Monitor
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- JumpCode Genomics, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2024-08-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-08-22.
- OVITZ CORPORATION
NIH R43: AI-Driven Tools for Automated Design of Higher Order Aberration Optics in Contact Lenses
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Myosin Therapeutics Inc.
Form D history: Pharmaceuticals
startup · FL · amount not stated · 2023-03-24
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-03-24.
- ALLEVIATE SOLUTIONS INC
NIH R41: Refinement of a novel at-home kit for contact dermatitis testing and diagnosis.
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.